CH605808A5 - - Google Patents

Info

Publication number
CH605808A5
CH605808A5 CH1621173A CH1621173A CH605808A5 CH 605808 A5 CH605808 A5 CH 605808A5 CH 1621173 A CH1621173 A CH 1621173A CH 1621173 A CH1621173 A CH 1621173A CH 605808 A5 CH605808 A5 CH 605808A5
Authority
CH
Switzerland
Application number
CH1621173A
Inventor
Rolf Wilhelm Pfirrmann
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Publication of CH605808A5 publication Critical patent/CH605808A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1621173A 1972-11-20 1973-11-19 CH605808A5 (US06229276-20010508-P00081.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5343772A GB1408010A (en) 1972-11-20 1972-11-20 Sulphamoylphenyl-imidazolidinones

Publications (1)

Publication Number Publication Date
CH605808A5 true CH605808A5 (US06229276-20010508-P00081.png) 1978-10-13

Family

ID=10467808

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1621173A CH605808A5 (US06229276-20010508-P00081.png) 1972-11-20 1973-11-19
CH1601476A CH605802A5 (US06229276-20010508-P00081.png) 1972-11-20 1973-11-19
CH1393177A CH603594A5 (US06229276-20010508-P00081.png) 1972-11-20 1973-11-19

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1601476A CH605802A5 (US06229276-20010508-P00081.png) 1972-11-20 1973-11-19
CH1393177A CH603594A5 (US06229276-20010508-P00081.png) 1972-11-20 1973-11-19

Country Status (21)

Country Link
US (1) US3963706A (US06229276-20010508-P00081.png)
JP (1) JPS541312B2 (US06229276-20010508-P00081.png)
AR (1) AR211379Q (US06229276-20010508-P00081.png)
AT (1) AT330766B (US06229276-20010508-P00081.png)
AU (1) AU470359B2 (US06229276-20010508-P00081.png)
BE (1) BE807490A (US06229276-20010508-P00081.png)
CA (1) CA1021783A (US06229276-20010508-P00081.png)
CH (3) CH605808A5 (US06229276-20010508-P00081.png)
DE (1) DE2357591C3 (US06229276-20010508-P00081.png)
DK (1) DK138645B (US06229276-20010508-P00081.png)
ES (1) ES420661A1 (US06229276-20010508-P00081.png)
FI (1) FI57934C (US06229276-20010508-P00081.png)
FR (1) FR2206947B1 (US06229276-20010508-P00081.png)
GB (1) GB1408010A (US06229276-20010508-P00081.png)
HU (1) HU170143B (US06229276-20010508-P00081.png)
IE (1) IE39319B1 (US06229276-20010508-P00081.png)
IL (1) IL43652A (US06229276-20010508-P00081.png)
NL (1) NL7315807A (US06229276-20010508-P00081.png)
PL (1) PL97758B1 (US06229276-20010508-P00081.png)
SE (1) SE417960B (US06229276-20010508-P00081.png)
ZA (1) ZA738824B (US06229276-20010508-P00081.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332542B1 (en) 1999-12-06 2015-02-11 Geistlich Pharma AG Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
YU52403A (sh) * 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
US6753328B2 (en) 2001-10-01 2004-06-22 Rhode Island Hospital Methods of inhibiting metastases
US20060293315A1 (en) * 2001-12-21 2006-12-28 Dr. Reddy's Laboratories Ltd. Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1472625A (US06229276-20010508-P00081.png) * 1965-03-31 1967-05-24

Also Published As

Publication number Publication date
HU170143B (US06229276-20010508-P00081.png) 1977-04-28
ZA738824B (en) 1974-09-25
FI57934B (fi) 1980-07-31
DE2357591C3 (de) 1980-02-28
IE39319L (en) 1974-05-20
FI57934C (fi) 1980-11-10
US3963706A (en) 1976-06-15
JPS541312B2 (US06229276-20010508-P00081.png) 1979-01-23
CH605802A5 (US06229276-20010508-P00081.png) 1978-10-13
DE2357591A1 (de) 1974-05-22
ES420661A1 (es) 1976-04-01
AT330766B (de) 1976-07-26
CH603594A5 (US06229276-20010508-P00081.png) 1978-08-31
JPS4993362A (US06229276-20010508-P00081.png) 1974-09-05
IL43652A (en) 1977-10-31
FR2206947B1 (US06229276-20010508-P00081.png) 1977-10-28
PL97758B1 (pl) 1978-03-30
AR211379Q (es) 1977-12-15
DK138645C (US06229276-20010508-P00081.png) 1979-03-19
IE39319B1 (en) 1978-09-13
GB1408010A (en) 1975-10-01
NL7315807A (US06229276-20010508-P00081.png) 1974-05-22
FR2206947A1 (US06229276-20010508-P00081.png) 1974-06-14
SE417960B (sv) 1981-04-27
AU470359B2 (en) 1975-05-22
CA1021783A (en) 1977-11-29
ATA968773A (de) 1975-10-15
DE2357591B2 (de) 1979-07-05
BE807490A (fr) 1974-05-20
DK138645B (da) 1978-10-09
IL43652A0 (en) 1974-03-14
AU6266073A (en) 1975-05-22

Similar Documents

Publication Publication Date Title
FR2193830B1 (US06229276-20010508-P00081.png)
JPS4935790A (US06229276-20010508-P00081.png)
FR2190964B1 (US06229276-20010508-P00081.png)
NO135900C (US06229276-20010508-P00081.png)
FR2196910A1 (US06229276-20010508-P00081.png)
JPS524611Y2 (US06229276-20010508-P00081.png)
JPS5230604B2 (US06229276-20010508-P00081.png)
JPS4950913A (US06229276-20010508-P00081.png)
JPS5215781Y2 (US06229276-20010508-P00081.png)
JPS5146729Y2 (US06229276-20010508-P00081.png)
JPS5413661B2 (US06229276-20010508-P00081.png)
JPS494271U (US06229276-20010508-P00081.png)
JPS5240572B2 (US06229276-20010508-P00081.png)
JPS48108590U (US06229276-20010508-P00081.png)
JPS4948345U (US06229276-20010508-P00081.png)
FR2184414A1 (US06229276-20010508-P00081.png)
JPS4899900U (US06229276-20010508-P00081.png)
FR2172013A1 (US06229276-20010508-P00081.png)
JPS4942126U (US06229276-20010508-P00081.png)
JPS48104054U (US06229276-20010508-P00081.png)
FR2192927A1 (US06229276-20010508-P00081.png)
CH583094A5 (US06229276-20010508-P00081.png)
CH576979A5 (US06229276-20010508-P00081.png)
CH584416A5 (US06229276-20010508-P00081.png)
CH574911A5 (US06229276-20010508-P00081.png)

Legal Events

Date Code Title Description
PL Patent ceased